Journal article

TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, And this cannot be rescued by wild-type bone marrow

LM Judd, HV Chalinor, A Walduck, DI Pavlic, J Däbritz, Z Dubeykovskaya, TC Wang, TR Menheniott, AS Giraud

American Journal of Physiology Gastrointestinal and Liver Physiology | Published : 2015

Abstract

The trefoil factor TFF2 is a member of a tripartite family of small proteins that is produced by the stomach and the colon. Recombinant TFF2, when applied intrarectally in a rodent model of hapten colitis, hastens mucosal healing and reduces inflammatory indexes. Additionally, TFF2 is expressed in immune organs, supporting a potential immunomodulatory and reparative role in the bowel. In this study we confirm that TFF2 is expressed in the colon and is specifically enriched in epithelial cells relative to colonic leukocytes. TFF2-deficient, but not TFF1-deficient, mice exhibit a more severe response to acute or chronic dextran sulfate (DSS)-induced colitis that correlates with a 50% loss of e..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Deutsche Forschungsgemeinschaft


Funding Acknowledgements

This work was supported by a Project Grant (1006542), Career Development Awards (L. M. Judd and T. R. Menheniott), a fellowship from the German Research Foundation (J. Dabritz), and a Senior Research Fellowship (A. S. Giraud) from the National Health and Medical Research Council of Australia, as well as the Victorian Government's Operational Infrastructure Support Program.